Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir

BACKGROUND/AIMS: Tenofovir disoproxil fumarate (TDF) monotherapy for 48 weeks provided a virological response comparable to that of TDF and entecavir (ETV) combination therapy in patients infected with ETV-resistant hepatitis B virus (HBV). Little long-term data in routine clinical practice are avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Hee-Jeong, Jung, Seok Won, Park, Neung Hwa, Yang, Yujin, Noh, Jin-Hee, Ahn, Jae-Sung, Kim, Hyung Rae, Lee, Jae Ho, Shin, Jung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628011/
https://www.ncbi.nlm.nih.gov/pubmed/28669175
http://dx.doi.org/10.3350/cmh.2017.0003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628011/
https://www.ncbi.nlm.nih.gov/pubmed/28669175
http://dx.doi.org/10.3350/cmh.2017.0003

Ejemplares similares